Who owns Celldex Therapeutics?

Key details on Celldex Therapeutics (Ticker: CLDX)

Who owns Celldex Therapeutics?

Is CLDX a good stock to own? Find out who bought Celldex Therapeutics, who sold Celldex Therapeutics (CLDX) stock, and who holds a large position in Celldex Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 12.06M $156.30M Sept. 30, 2014
Franklin Resources 10.23M $132.55M Sept. 30, 2014
OppenheimerFunds 8.82M $114.35M Sept. 30, 2014
Vanguard 5.20M $67.42M Sept. 30, 2014
Columbia Wanger Asset Management 3.57M $46.29M Sept. 30, 2014
BlackRock Fund Advisors 3.03M $39.32M Sept. 30, 2014
Jennison Associates 3.03M $39.24M Sept. 30, 2014
STATE STREET CORPORATION 2.55M $33.08M Sept. 30, 2014
HealthCor Management 2.50M $8.88M June 30, 2011
SUSQUEHANNA INTERNATIONAL 2.49M $32.31M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.41M $31.22M Sept. 30, 2014
OrbiMed Advisors 2.18M $28.27M Sept. 30, 2014
TimesSquare Capital Management 2.04M $26.39M Sept. 30, 2014
S.A.C. Capital Advisors 1.82M $32.14M March 31, 2014
LORD, ABBETT & CO 1.69M $27.54M June 30, 2014
Wellington Management Company 1.62M $25.26M June 30, 2013
HealthCor Management 1.45M $22.63M June 30, 2013
Sectoral Asset Management 1.41M $24.90M March 31, 2014
ALLIANCEBERNSTEIN 1.24M $44.04M Sept. 30, 2013
First Eagle Investment Management 1.23M $14.24M March 31, 2013
BlackRock Advisors 1.21M $42.85M Sept. 30, 2013
NORTHERN TRUST 1.17M $20.63M March 31, 2014
DIMENSIONAL FUND ADVISORS 1.14M $27.48M Dec. 31, 2013
Columbus Circle Investors 1.11M $14.33M Sept. 30, 2014
TSP Capital Management 1.09M $17.03M June 30, 2013

Who sold Celldex Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ridgeback Capital Investments Dec. 31, 2012 3.80M $25.53M